1. Bateman ED A randomised, double-blind, placebo-controlled, parallel-group study to assess long term (one-year) efficacy and safety of tiotropium inhalation solution 5 mcg (2 puffs of 2.5 mcg) delivered by the Respimat® inhaler in patients with chronic obstructive pulmonary disease (COPD) www.trials.boehringer-ingelheim.com
2. A one-year trial of tiotropium Respimat plus usual therapy in COPD patients;Bateman;Respiratory Medicine,2010
3. Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies;Bateman;International Journal of Chronic Obstructive Pulmonary Disease,2010
4. Cooper C A retrospective collection of vital status and pulmonary medication usage data for patients with chronic obstructive pulmonary disease (COPD) who withdrew prematurely from either of two one-year trials (205.254, 205.255) of tiotropium inhalation solution delivered by the Respimat® inhaler www.trials.boehringer-ingelheim.com
5. Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat Soft Mist Inhaler in COPD;Hodder;International Journal of Chronic Obstructive Pulmonary Disease,2011